JPS58185520A - 血糖調節剤 - Google Patents

血糖調節剤

Info

Publication number
JPS58185520A
JPS58185520A JP6568982A JP6568982A JPS58185520A JP S58185520 A JPS58185520 A JP S58185520A JP 6568982 A JP6568982 A JP 6568982A JP 6568982 A JP6568982 A JP 6568982A JP S58185520 A JPS58185520 A JP S58185520A
Authority
JP
Japan
Prior art keywords
blood sugar
sugar level
dihydroxycholecalciferol
agent
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6568982A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6221332B2 (enExample
Inventor
Yuji Maeda
裕司 前田
Hideyuki Yamato
英之 大和
Takami Fujii
藤井　孝美
Yasuhiko Kobayashi
靖彦 小林
Kenichi Saito
健一 斉藤
Masanori Ubusawa
生沢　政則
Tadaaki Kato
加藤　侃明
Chikao Yoshikumi
吉汲　親雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP6568982A priority Critical patent/JPS58185520A/ja
Priority to US06/374,702 priority patent/US4442093A/en
Priority to BE0/208097A priority patent/BE893193A/fr
Priority to IT21278/82A priority patent/IT1190824B/it
Publication of JPS58185520A publication Critical patent/JPS58185520A/ja
Publication of JPS6221332B2 publication Critical patent/JPS6221332B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6568982A 1981-05-15 1982-04-20 血糖調節剤 Granted JPS58185520A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP6568982A JPS58185520A (ja) 1982-04-20 1982-04-20 血糖調節剤
US06/374,702 US4442093A (en) 1981-05-15 1982-05-04 Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
BE0/208097A BE893193A (fr) 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
IT21278/82A IT1190824B (it) 1981-05-15 1982-05-14 Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6568982A JPS58185520A (ja) 1982-04-20 1982-04-20 血糖調節剤

Publications (2)

Publication Number Publication Date
JPS58185520A true JPS58185520A (ja) 1983-10-29
JPS6221332B2 JPS6221332B2 (enExample) 1987-05-12

Family

ID=13294221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6568982A Granted JPS58185520A (ja) 1981-05-15 1982-04-20 血糖調節剤

Country Status (1)

Country Link
JP (1) JPS58185520A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109722A (ja) * 1984-11-01 1986-05-28 Kureha Chem Ind Co Ltd 抗糖尿病性骨減少症剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03120740U (enExample) * 1990-03-23 1991-12-11

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109722A (ja) * 1984-11-01 1986-05-28 Kureha Chem Ind Co Ltd 抗糖尿病性骨減少症剤

Also Published As

Publication number Publication date
JPS6221332B2 (enExample) 1987-05-12

Similar Documents

Publication Publication Date Title
US3174901A (en) Process for the oral treatment of diabetes
RU2201272C2 (ru) Применение ингибиторов желудочно-кишечной липазы
US4673691A (en) Human weight loss inducing method
Ulukaya et al. Acute amitraz intoxication in human
JPH0261477B2 (enExample)
Harris Case 24-2006: a 40-year-old woman with hypotension after an overdose of amlodipine
US3658966A (en) Methods of treating hypertension
JP2007099764A (ja) 血糖低下剤
JPS62120317A (ja) 痴呆症状改善・治療剤
CA2850919C (en) Choline composition
Arena et al. Salicylate-induced hypoglycemia and ketoacidosis in a nondiabetic adult
RU2543635C2 (ru) Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости
JPS58185520A (ja) 血糖調節剤
Ridgway et al. Therapy of primary hypothyroidism with L‐triiodothyronine: discordant cardiac and pituitary responses
CH651556A5 (en) Salt of (benzylindazolyl)oxyacetic acid, process for the preparation of this salt and pharmaceutical composition containing this salt
JPH01186883A (ja) 抗アテローム性動脈硬化症剤としてのｄｌ‐５‐〔（２ベンジル‐３，４‐ジヒドロ‐２Ｈ‐ベンゾピラン‐６‐イル）メチル〕チアゾリジン‐２，４‐ジオン
US6194466B1 (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
JPS6259219A (ja) 外用鎮咳・去痰・鎮痛・鎮静剤
US4042698A (en) Treatment of myasthenia gravis and oral medication therefor
Sindoni Fasting blood sugar vs. postprandial blood sugar as observed in normal individuals, medical (non-diabetic) patients, and patients with diabetes: special references to: plain, protamine zinc and globin insulins, compatible hyperglycemia and arteriosclerosis
BARTELS CLINICAL EXPERIENCE WITH A NEW ANTITHYROID DRUG: 2-CARBETH0XYTHI0-1-METHYLGLYOX ALINE
US3852353A (en) Oral hypoglycemic aminophenylsulfonyl-hydrocarbylbiguanides
US3929999A (en) Oral hypoglycemic method
Svedmyr et al. Effects of sotalol and propranolol administered orally in man
US3296074A (en) Methods and compositions for treating psychoses and neuroses